HJURP and central nervous system cancer: Silencing of HJURP in glioma cells resulted in prominent morphological changes paralleled by significantly decreased viability, increased apoptosis, cell cycle arrest in the G2/M phase, and accelerated senescence (Serafim et al., 2020).